Objectives: The aim of this study is to describe the differences in Patients Diagnostic Therapeutic Pathways (PDTA) among Italian Regions, as the Italian scenario shows substantial differences in terms of Regional guidelines, organization and allocated budget.

Lanati, E., Lidonnici, D., Gasbarrini, A., Ruggeri, M., Sacchini, D., Caporaso, N., Fagiuoli, S., Patients Diagnostic Therapeutic Pathways For Hcv Patients In Italy: Impact Of Regionalization In Treatments And Guidelines., <<VALUE IN HEALTH>>, 2014; 17 (7): 372-372. [doi:http://dx.doi.org/10.1016/j.jval.2014.08.852] [http://hdl.handle.net/10807/64986]

Patients Diagnostic Therapeutic Pathways For Hcv Patients In Italy: Impact Of Regionalization In Treatments And Guidelines.

D; Gasbarrini;Antonio; Ruggeri;Matteo; Sacchini;
2014

Abstract

Objectives: The aim of this study is to describe the differences in Patients Diagnostic Therapeutic Pathways (PDTA) among Italian Regions, as the Italian scenario shows substantial differences in terms of Regional guidelines, organization and allocated budget.
Inglese
Lanati, E., Lidonnici, D., Gasbarrini, A., Ruggeri, M., Sacchini, D., Caporaso, N., Fagiuoli, S., Patients Diagnostic Therapeutic Pathways For Hcv Patients In Italy: Impact Of Regionalization In Treatments And Guidelines., <<VALUE IN HEALTH>>, 2014; 17 (7): 372-372. [doi:http://dx.doi.org/10.1016/j.jval.2014.08.852] [http://hdl.handle.net/10807/64986]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/64986
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 0
social impact